PASSAGE BIO, INC.
Balance Sheet
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Assets | |||||||
| Cash & Equivalents | $46.3M | $37.6M | $21.7M | $34.6M | $129.0M | $135.0M | $158.9M |
| Accounts Receivable | — | — | — | — | — | — | — |
| Inventory | — | — | — | — | — | — | — |
| Total Current Assets | $47.8M | $78.8M | $118.0M | $197.0M | $325.1M | $317.2M | $165.8M |
| Property, Plant & Equipment | $4.1M | $9.3M | $15.3M | $22.5M | $23.8M | $2.8M | $1.1M |
| Goodwill | — | — | — | — | — | — | — |
| Intangible Assets (Excl. Goodwill) | — | — | — | — | — | — | — |
| Total Assets | $62.3M | $102.4M | $150.5M | $243.5M | $355.1M | $328.0M | $178.6M |
| Liabilities | |||||||
| Accounts Payable | $1.1M | $742.0K | $1.3M | $4.1M | $9.4M | $5.3M | $629.0K |
| Total Current Liabilities | $23.1M | $19.4M | $16.3M | $18.4M | $29.5M | $21.2M | $3.7M |
| Long-Term Debt | — | — | — | — | — | — | — |
| Total Liabilities | $43.5M | $41.2M | $39.3M | $42.2M | $36.4M | $23.3M | $4.3M |
| Stockholders' Equity | |||||||
| Retained Earnings | $-704.8M | $-659.2M | $-594.5M | $-492.4M | $-356.3M | $-170.9M | $-58.7M |
| Total Stockholders' Equity | $18.8M | $61.3M | $111.3M | $201.4M | $318.7M | $304.7M | $-56.3M |